Skip to content
Screener

EBIT at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.14B+7.4%
Stryker logo
StrykerSYK
$1.66B+49.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$8.13M+49.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$22.58M+49.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.48M-37.6%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$377.32M+11.1%
Enterprise value$353M
P/S

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Debt / equity0.3×
Current ratio8.8×+4.0×

Where this comes from

Calculated from Carlsmed, Inc.’s reported figures.

The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001794546-26-000016

FAQ

What is Carlsmed, Inc.'s EBIT?
Carlsmed, Inc. (CARL) reported EBIT of -$11.04M in Q2 2026.
How has Carlsmed, Inc.'s EBIT changed year-over-year?
Carlsmed, Inc.'s EBIT decreased by 69.7% year-over-year, from -$6.5M to -$11.04M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Ask your AI about Carlsmed, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude